First Patient Treated in Study Testing Aleva’s directSTIM DBS System
Aleva Neurotherapeutic’s innovative directional deep brain stimulation (DBS) system — called directSTIM — for Parkinson’s disease has been implanted in the first patient participating in a German study. That study, which aims to demonstrate improved outcomes when using this DBS technology in individuals with Parkinson’s and essential tremor,…